DELETION OF SEQUENCES UPSTREAM OF THE PROTEINASE IMPROVES THE PROTEOLYTIC PROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:64
|
作者
PARTIN, K
ZYBARTH, G
EHRLICH, L
DECROMBRUGGHE, M
WIMMER, E
CARTER, C
机构
[1] SUNY STONY BROOK, DEPT MICROBIOL, STONY BROOK, NY 11794 USA
[2] DUKE UNIV, HOWARD HUGHES MED INST, DURHAM, NC 27706 USA
关键词
ASPARTIC PROTEINASES; ZYMOGEN ACTIVATION; VIRAL MATURATION;
D O I
10.1073/pnas.88.11.4776
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus type 1 expresses structural proteins and replicative enzymes within gag and gag-pol precursor polyproteins. Specific proteolytic processing of the precursors by the viral proteinase is essential for maturation of infectious viral particles. We have studied the activity of proteinase in its immature form, as part of a gag-pol fusion protein, in an in vitro expression system. We found that deletion of p6*, the region in pol upstream of proteinase, resulted in improved processing of the precursor. A modified proteinase is released, but it functions less efficiently than wild type. Improved autoprocessing correlates with increased accessibility of the active site region in the polyprotein carrying the p6* deletion. Our results suggest that p6* is involved in the regulation of proteinase activation, perhaps as a region limiting the interaction of the active site and substrate binding domain with the remainder of the polyprotein. Release of p6* inhibition may be an activation step necessary for infectious particle maturation.
引用
收藏
页码:4776 / 4780
页数:5
相关论文
共 50 条
  • [21] RENAL COMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOURGOIGNIE, JJ
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1571 - 1584
  • [22] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162
  • [23] DETECTION OF PROVIRAL SEQUENCES IN SALIVA OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GOTO, Y
    YEH, CK
    NOTKINS, AL
    PRABHAKAR, BS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (03) : 343 - 347
  • [24] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [25] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE - THE ROAD FROM AN ACCESSORY TO AN ESSENTIAL ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    VOLSKY, DJ
    POTASH, MJ
    SIMM, M
    SOVA, P
    MA, XY
    CHAO, W
    SHAHABUDDIN, M
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 157 - 168
  • [26] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [27] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [28] PROCESSING OF DEOXYURIDINE MISMATCHES AND ABASIC SITES BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE
    MAZUMDER, A
    POMMIER, Y
    NUCLEIC ACIDS RESEARCH, 1995, 23 (15) : 2865 - 2871
  • [29] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE IS RAPIDLY AND EFFICIENTLY INACTIVATED IN HUMAN PLASMA BY ALPHA(2)-MACROGLOBULIN
    KISSELEV, AF
    VONDERHELM, K
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (10): : 711 - 714
  • [30] CONSERVED V3 LOOP SEQUENCES AND TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SHPAER, EG
    DELWART, EL
    KUIKEN, CL
    GOUDSMIT, J
    BACHMANN, MH
    MULLINS, JI
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1679 - 1684